We are very happy to inform you that the launch of the 2022 EAHAD membership cycle brought with it a new benefit: full access to past Congress recordings!
The EAHAD Nurse Committee currently has two vacant spots and is inviting nurses involved in haemophilia and bleeding disorders care to apply. The positions are for a three-year term that would begin in February 2022.
Become an EAHAD 2022 Social Media Ambassador! We’re looking for applicants who will actively engage in social media to help us further promote the EAHAD 2022 scientific programme covering the latest in the haemophilia and bleeding disorders field.
We are very happy to inform you that at the last Executive Committee meeting, the members decided to turn the Psychosocial Professionals Working Group into a standing committee of EAHAD.
We are very happy to inform you that the newest issue of the EAHAD Physiotherapists Newsletter has been published.
We are delighted to inform you that our Women and Bleeding Disorders Working Group just published their 10 Women and Girls with Bleeding Disorders European Principles of Care in Haemophilia Journal.
The 2020 EAHAD Annual Report has just been published. In it, you will find information on all EAHAD-related activities of the past year.
We are inviting haemophilia physiotherapists to apply for one vacant post on our Physiotherapists Committee. The position is for a three-year term that would begin in February 2022.
Physiotherapists Committee membership offers an opportunity to contribute to the development and implementation of physiotherapy and inter-professional EAHAD projects and events, including the Allied Health Professionals Pre-Congress Day.
After careful consideration, the EAHAD 2022 Organising Committee has decided that, due to the persistent worldwide impact and remaining uncertainty around the COVID-19 crisis, EAHAD 2022, our 15th Congress, taking place from 2-4 February 2022, will be a fully virtual event.
We are very happy to join the European Alliance for Transformative Therapies (TRANSFORM), a multi-stakeholder initiative aiming to foster effective dialogue around cell and gene therapy and provide evidence-based policy recommendations to enable safe and timely patient access to these therapies.